Results for tag: "Cinryze"

Cinryze is a brand of immune disorder drugs used to treat hereditary angioedema (HAE). It is a rare, genetic disorder that causes episodes of swelling in the face, extremities, gastrointestinal tract, and airway. Cinryze is a C1 esterase inhibitor (C1-INH) that works by replacing the missing or deficient C1-INH protein in the body. It is administered intravenously and is used to prevent and treat HAE attacks. Cinryze is the only FDA-approved C1-INH therapy for HAE and is the only therapy approved for routine prophylaxis. The Cinryze market is composed of a variety of companies that produce and distribute C1-INH therapies. These companies include Shire, CSL Behring, Pharming Group, and ViroPharma. Additionally, there are several generic versions of C1-INH therapies available in the market. Show Less Read more